CLNN

Clene Inc.

0.44 USD
+0.01 (+1.38%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Clene Inc. stock is down -15.38% since 30 days ago. The next earnings date is Mar 11, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 5 February’s closed higher than January. 100% of analysts rate it a buy.

About Clene Inc.

Clene Inc. focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis. The company also markets and distributes dietary supplements.